Global benchmarks for minimally invasive right hemicolectomy for cancer - Report - MDSpire

Global benchmarks for minimally invasive right hemicolectomy for cancer

  • By

  • Fariba Abbassi

  • Michaela Ramser

  • Matthias Pfister

  • Roxane D Staiger

  • Sun J Kim

  • Ji W Park

  • Bart C T van de Laar

  • Marcos Gonzalez

  • Vittoria Perano

  • Georgette Camilleri

  • David Merino

  • Justin Dourado

  • Anjelli Wignakumar

  • Kohei Shigeta

  • Tomás Mansur Duarte de Miranda Marques

  • Daniel Leonard

  • Kai-Yin Lee

  • Avanish Saklani

  • Kilian G M Brown

  • Fabio Butti

  • Ivana Raguz

  • Carlo Alberto Schena

  • Daichi Kitaguchi

  • Desmond C Winter

  • Masaaki Ito

  • Nicola de’Angelis

  • Dieter Hahnloser

  • Jennifer Vu

  • Ashwin Desouza

  • Bei-En Siew

  • Ker-Kan Tan

  • Alex Kartheuser

  • Samuel Aguiar

  • Koji Okabayashi

  • Carl J Brown

  • Steven Wexner

  • Sebastiano Biondo

  • Danilo Miskovic

  • Antonino Spinelli

  • Carlos A Vaccaro

  • Esther C J Consten

  • Byung S Min

  • Milo A Puhan

  • Matthias Turina

  • December 16, 2025

  • 0 min

Share

International Standards for Minimally Invasive Right Hemicolectomy in Cancer Treatment

Overview

This study establishes international benchmark cut-offs for elective minimally invasive right hemicolectomy in patients with right-sided colon adenocarcinoma. Using data from high-volume specialist centres worldwide, the benchmarks define best achievable outcomes in ideal low-risk patients, facilitating quality comparisons and improvements in surgical care.

Background

Colorectal cancer is a leading cause of cancer morbidity and mortality globally, with approximately 20% of cases located in the right colon. Right hemicolectomy following oncological principles, including complete mesocolic excision and central lymphadenectomy, is the standard surgical treatment. Minimally invasive techniques such as laparoscopy and robotic surgery have become standard, but unlike rectal cancer, right colon cancer surgery is often performed in low-volume centres, highlighting the need for standardized quality benchmarks.

Data Highlights

The study included consecutive elective minimally invasive right hemicolectomies performed between July 2017 and June 2022 for adenocarcinoma of the cecum or ascending colon. Patients were stratified into ideal (low-risk) and non-ideal (high-risk) groups based on established risk factors. Nineteen clinically relevant outcome parameters were collected, including perioperative data, oncological results, complications graded by Clavien–Dindo classification, and morbidity assessed by the Comprehensive Complication Index® at discharge, 3 months, and 6 months postoperatively.

Key Findings

  • Benchmark cut-offs were derived from ideal low-risk patients treated at high-volume colorectal specialist centres internationally.
  • Nineteen outcome parameters encompassing perioperative, oncological, and complication metrics were standardized for benchmarking.
  • Risk stratification into ideal and non-ideal groups allowed for meaningful comparison and quality assessment.
  • Minimum centre contribution of ten ideal patients ensured robustness of benchmark data.
  • The benchmarking approach facilitates identification of quality gaps and areas for surgical improvement in minimally invasive right hemicolectomy.

Clinical Implications

These international benchmarks provide surgeons and centres with reference standards for minimally invasive right hemicolectomy outcomes, enabling objective performance evaluation. Adoption of these benchmarks can guide quality improvement initiatives, optimize surgical techniques, and ultimately improve patient outcomes in right-sided colon cancer treatment.

Conclusion

The establishment of international benchmark cut-offs for minimally invasive right hemicolectomy offers a validated tool for quality assurance and outcome comparison. This framework supports continuous improvement in surgical care for patients with right-sided colon adenocarcinoma.

References

  1. Collaborative Research Proceedings -- International Standards for Minimally Invasive Right Hemicolectomy in Cancer Treatment

Original Source(s)

Global benchmarks for minimally invasive right hemicolectomy for cancer

  • by Fariba Abbassi, Michaela Ramser, Matthias Pfister, Roxane D Staiger, Sun J Kim, Ji W Park, Bart C T van de Laar, Marcos Gonzalez, Vittoria Perano, Georgette Camilleri, David Merino, Justin Dourado, Anjelli Wignakumar, Kohei Shigeta, Tomás Mansur Duarte de Miranda Marques, Daniel Leonard, Kai-Yin Lee, Avanish Saklani, Kilian G M Brown, Fabio Butti, Ivana Raguz, Carlo Alberto Schena, Daichi Kitaguchi, Desmond C Winter, Masaaki Ito, Nicola de’Angelis, Dieter Hahnloser, Jennifer Vu, Ashwin Desouza, Bei-En Siew, Ker-Kan Tan, Alex Kartheuser, Samuel Aguiar, Koji Okabayashi, Carl J Brown, Steven Wexner, Sebastiano Biondo, Danilo Miskovic, Antonino Spinelli, Carlos A Vaccaro, Esther C J Consten, Byung S Min, Milo A Puhan, Matthias Turina

  • December 16, 2025

Related Content

European Delphi consensus on specific training, implementation requirements, and clinical use for the Hugo™ robotic-assisted surgery platform in colorectal procedures

Postoperative Step Counts Tied to Surgical Recovery

Wearable-measured mobility—but not heart rate variability or wellness scores—was associated with length of stay, complications, and readmissions

Comparison of the mixed approach and medial approach in laparoscopic right hemicolectomy for right colon cancer: a retrospective study